Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.
Jackson DJ, Pelaia G, Emmanuel B, Tran TN, Cohen D, Shih VH, Shavit A, Arbetter D, Katial R, Rabe APJ, Garcia Gil E, Pardal M, Nuevo J, Watt M, Boarino S, Kayaniyil S, Chaves Loureiro C, Padilla-Galo A, Nair P.
Jackson DJ, et al. Among authors: kayaniyil s.
Eur Respir J. 2024 Jul 11;64(1):2301521. doi: 10.1183/13993003.01521-2023. Print 2024 Jul.
Eur Respir J. 2024.
PMID: 38575162
Free PMC article.